Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Nabla Bionabla.bioNabla Bio is a drug development company that combines generative AI with large-scale human-relevant testing to design new medicines. Their platform aims to reduce trial and error by engineering drugs with desired properties like binding, developability, and in vivo performance.
Parse Score
Sources
reuters.com shapes more of what AI says about Nabla Bio than any other source, at 25% of its citations.
techlifesci.com · aijourn.com · genengnews.com · medium.com
Excerpts where Nabla Bio appeared in the AI's answer
Nabla Bio (JAM Platform) : Uses its Joint Atomic Modelling (JAM) multimodal generative system
Nabla Bio: Specializes in generative models (like their Joint Atomic Model)
Excerpts where Nabla Bio appeared in the AI's answer
Nabla Bio : Specialized in AI-driven protein engineering for antibody drug discovery.
Nabla Bio : Focuses on AI-driven antibody design and engineering, specifically aiming at complex targets.
